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Nervin Fanous, MD, S. Adil Husain, MD, Mark Ruzmetov, MD, PhD,
Mark D. Rodefeld, MD, Mark W. Turrentine, MD, and John W. Brown, MD,
Indianapolis, Ind, and San Antonio, Tex
Twenty-six patients with tracheal stenosis underwent anterior pericardial tracheoplasty over a 25-year
period. An average of 14 tracheal rings (range, 5–22) was divided anteriorly, and a patch of fresh
autologous pericardium was used to enlarge the trachea to 1.5 times the predicted diameter for age and
weight. There were 3 hospital deaths; no deaths were related to airway obstruction. All survivors
remain asymptomatic, with minimal to no evidence of airway obstruction. Anterior pericardial
tracheoplasty for tracheal stenosis provides excellent results in the majority of patients at long-term
follow-up.PM
S26 Biodegradable polymer coating promotes the epithelization of
tissue-engineered airway prostheses
Toshihiko Sato, MD, Masato Araki, MD, Naoki Nakajima, PhD, Koichi Omori, MD, and
Tatsuo Nakamura, MD, Kyoto, Nagasaki, and Fukushima, Japan
A multilayered prosthesis was designed for replacement of the left main bronchus. The luminal
surface of the prosthesis was coated with a biodegradable polymer. The biodegradable polymer was
shown to protect the underlying collagen layer from early disintegration and promoted tissue
regeneration in a canine model.(continued on page 16A)
The Journal of Thoracic and Cardiovascular Surgery c Volume 139, Number 1 15A
ET
/B
Table of Contents (continued)
16A The Journal of Thoracic an
G
TS
A
CD
CH
D
TX
PM
ET/B
S32 Fibrocollagen-covered prosthesis for a noncircumferential segmental
tracheal replacement
Fernando Villegas-A´lvarez, MD, Jose´ F. Gonza´lez-Zamora, MD, Angelica Gonza´lez-Maciel,
Rosa Soriano-Rosales, Beatriz Pe´rez-Guille, Luis Padilla-Sa´nchez, MD, Rafael Reynoso-Robles,
Andrea Ramos-Morales, Edgar Zenteno-Galindo, MD, Armando Pe´rez-Torres, MD, and
Eduardo E. Montalvo-Jave, MD, FACS, Mexico City, Mexico
A collagen-coated polyester prosthesis is able to promote the formation of normal ciliated
epithelium in the trachea. This prosthesis was used as a segmental noncircumferential tracheal
substitute in rats. It maintained tracheal function without collapse, chronic inflammation, or
secondary stenosis.
38 Required area of lymph node sampling during segmentectomy for
clinical stage IA non–small cell lung cancer
Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD, Hidekatsu Shibata, MD, Kenji Shiraishi, MD, PhD,Takeshi Mori, MD, PhD, and Shinya Shiraishi, MD, PhD, Kumamoto and Tokyo, Japan
Segmental sentinel nodes were found more frequently in resected than in nonresected segments.
However, anteriorly located segments were more likely to have sentinel nodes in the nonresected
posteriorly lying segment. Lymphadenectomy should be conducted for nonresected segments,
particularly for anteriorly located segments.
43 Survival of patients with distal esophageal and gastric cardia tumors:
A population-based analysis of gastroesophageal junction carcinomas
Bryan A. Whitson, MD, PhD, Shawn S. Groth, MD, Zhongze Li, MS, Robert A. Kratzke, MD,
and Michael A. Maddaus, MD, Minneapolis, Minn
The Surveillance, Epidemiology, and End Results database was used to evaluate whether the location
of gastroesophageal junction tumors (eg, the distal esophagus or gastric cardia) influences survival.
In multivariable analysis gastric cardia and distal esophageal tumors had similar overall and
cancer-specific survival rates.
49 Impaired quality of life after pneumonectomy: Who is at risk?
Francesco Leo, MD, PhD, Paolo Scanagatta, MD, Fernando Vannucci, MD,
Daniela Brambilla, MA, Davide Radice, PhD, and Lorenzo Spaggiari, MD, PhD, Milan, Italy
Quality of life (QoL) was investigated during the first 6 postoperative months in a cohort of 41
consecutive patients who underwent pneumonectomy. A clinically relevant impairment of QoL was
recorded in 10 cases (24.4%). Patients aged 70 years or more and those with low preoperative QoL
seem to be at risk for unsatisfactory QoL after surgery.
53 Thoracoscopic esophagectomy for esophageal cancer: Feasibility and
safety of robotic assistance in the prone position
Dae Joon Kim, MD, Woo Jin Hyung, MD, PhD, Chang Young Lee, MD, Jin-Gu Lee, MD,
Seok Jin Haam, MD, In-Kyu Park, MD, and Kyung Young Chung, MD, Seoul, Korea
Twenty-one patients with esophageal cancer underwent robot-assisted thoracoscopic esophagectomy
in the prone position with no mortality or pulmonary complications. A rapidly diminishing robot
console time, less blood loss, and more immediate extubation were noted in the latter 15 patients.
Preoperative risk assessment and meticulous anesthetic manipulation are necessary for this
procedure.(continued on page 18A)
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Disease (ACD)18A The Journal of Thoracic an60 Comparable patencies of the radial artery and right internal thoracic artery
or saphenous vein beyond 5 years: Results from the Radial Artery
Patency and Clinical Outcomes trial
Philip A. R. Hayward, MRCP, FRCS, Ian R. Gordon, MSc, PhD, AStat, David L. Hare, DPM,
FRACP, George Matalanis, FRACS, Mark L. Horrigan, FRACP, Alexander Rosalion, FRACS, and
Brian F. Buxton, FRACS, FRCS, FRCS(C), Parkville and Melbourne, Victoria, Australia
Patients randomized to RA versus RITA or RA versus SV in an older aged cohort, for grafting the
largest non-LAD target, underwent protocol-directed angiography at 1 to 10 years. This shows similar
patencies at mean 5- to 6-year follow-up, with comparably low reintervention rates.
68 When is the Ross operation a good option to treat aortic valve disease?
Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, and Manjula Maganti, MSc,
Toronto, Ontario, Canada
The outcomes of the Ross operation at 15 years showed patients’ survival similar to that of the general
population, freedom from aortic valve reoperation of 92.1%, and freedom from aortic insufficiency of
greater than 21 of 63.2%. The best results were seen in female patients, those with aortic stenosis, and
those with an aortic annulus less than 27 mm in diameter.
76 Four decades of experience with mitral valve repair: Analysis of differential
indications, technical evolution, and long-term outcome
Daniel J. DiBardino, MD, Andrew W. ElBardissi, MD, R. Scott McClure, MD,
Ozwaldo A. Razo-Vasquez, MD, Nicole E. Kelly, RN, and Lawrence H. Cohn, MD, Boston, Mass
Follow-up data to 36 years after mitral valve repair for 4 different etiologies of mitral valve disease
showed that etiology strongly determines survival and durability of mitral valve repair. In all decades
operative mortality was low, averaging 1.5%. Myxomatous valve repair showed the longest
durability approaching 30 years postoperatively whereas rheumatic patients surviving beyond 20
years require reoperation. Functional mitral regurgitation carries the highest short- and long-term
mortality and the lowest freedom from reoperation.
85 Bosentan as a bridge to pulmonary endarterectomy for chronic
thromboembolic pulmonary hypertension
Herre J. Reesink, MD, PhD, Sulaiman Surie, MD, Jaap J. Kloek, MD, Hanno L. Tan, MD, PhD,
Robert Tepaske, MD, PhD, Peter F. Fedullo, MD, and Paul Bresser, MD, PhD, Amsterdam,
The Netherlands, and San Diego, Calif
In patients with proximal chronic thromboembolic pulmonary hypertension, treatment with bosentan
before pulmonary endarterectomy significantly improved pulmonary hemodynamics and functional
capacity. Bosentan might be of use to optimize the condition of patients with severe pulmonary
hypertension at risk for postoperative mortality or a more complicated postoperative course.
92 Detecting occult coronary artery disease followed by early coronary artery
bypass surgery in patients with diabetic retinopathy: Report from a diabetic
retinocoronary clinic
Takayuki Ohno, MD, PhD, Osamu Kinoshita, MD, Hideo Fujita, MD, PhD, Satoshi Kato, MD, PhD,
Akira Hirose, MD, PhD, Takashi Sigeeda, MD, PhD, Kazuyoshi Otomo, MD, Jiro Ando, MD, PhD,
Takashi Kadowaki, MD, PhD, Makoto Araie, MD, PhD, Ryozo Nagai, MD, PhD, and
Shinichi Takamoto, MD, PhD, Tokyo, Japan
We evaluated the incidence of occult coronary artery disease in patients with diabetic retinopathy. Of
214 patients with diabetic retinopathy receiving ophthalmologic care as outpatients in whom
coronary artery disease was not suspected, 55 (25.7%) had coronary artery disease. Forty-two had
indications for coronary revascularization.(continued on page 20A)
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S98 Basal cusp enlargement for repair of aortic valve insufficiency
Paul P. Urbanski, MD, Bad Naustadt, Germany
An initial experience with a novel cusp enlargement technique for the repair of aortic valve
insufficiency in complex aortic root and valve pathologies is described.
103 Long-term outcomes of percutaneous mitral balloon valvuloplasty
versus open cardiac surgery
Jae-Kwan Song, MD, Mi-Jeong Kim, MD, Sung-Cheol Yun, PhD, Suk Jung Choo, MD,
Jong-Min Song, MD, Hyun Song, MD, Duk-Hyun Kang, MD, Cheol Hyun Chung, MD,
Duk Woo Park, MD, Seung Whan Lee, MD, Young-Hak Kim, MD, Cheol Whan Lee, MD,
Myeong-Ki Hong, MD, Jae-Joong Kim, MD, Jae Won Lee, MD, Seong-Wook Park, MD, and
Seung-Jung Park, MD, Seoul, South Korea
Early randomized, controlled studies showing similar outcomes for both PMV and surgical techniques
suffer from insufficient statistical power. The present study found that OHS was associated with
a higher adjusted rate of long-term event-free survival than PMV. Patients with high
echocardiographic scores or atrial fibrillation showed better outcomes after OHS, suggesting that these
clinical variables should be seriously considered when choosing treatments for patients with MS.
111 Long-term outcome of modified maze procedure combined with
mitral valve surgery: Analysis of outcomes according to type of
mitral valve surgery
Joon Bum Kim, MD, Tae Jin Yun, MD, Cheol Hyun Chung, MD, Suk Jung Choo, MD,
Hyun Song, MD, and Jae Won Lee, MD, Seoul, South Korea
Maze outcomes were compared between mitral valve repair and replacement groups. There were
no intergroup differences in survival and morbidity. In multivariate analysis, recurrence of atrial
fibrillation was affected by age, electrocardiographic characteristics of atrial fibrillation, and larger
preoperative left atrial size, not by type of mitral valve surgery.Commentary 117 The quest to identify predictors for success and failure after the
Cox-Maze procedure for the treatment of atrial fibrillation
Niv Ad, MD, Falls Church, VaCongenital Heart
Disease (CHD)119 Evolution of treatment options and outcomes for hypoplastic left heart
syndrome over an 18-year period
Tara Karamlou, MD, Brian S. Diggs, PhD, Ross M. Ungerleider, MD, MPH, and
Karl F. Welke, MD, MSc, Portland, Ore, and Ann Arbor, Mich
National treatment for neonates with hypoplastic left heart syndrome has evolved over an 18-year
period favoring the Norwood operation compared with heart transplant concomitant with a linear
decrease in post-Norwood in-hospital mortality. Comfort care and transfer to definitive care facilities,
however, are still undertaken in the majority of patients.
128 Systemic arteriovenous fistulae for end-stage cyanosis after cavopulmonary
connection: A useful bridge to transplantation
Edward J. Hickey, MD, Abdullah A. Alghamdi, MD, Maryam Elmi, BSc,
Khalid S. Al-Najashi, MD, Glen S. Van Arsdell, Christopher A. Caldarone, MD,
John Coles, MD, and William G. Williams, MD, Toronto, Ontario, Canada
Systemic AVF may palliate intractable cyanosis after cavopulmonary connection. In our 30-year
experience, palliation with AVF was significantly less effective after total (vs partial) cavopulmonary
connection and when pulmonary arteriovenous malformations were present. AVF offered approximately
5-year bridge to transplantation. Three quarters of AVF recipients were alive 15 years later.(continued on page 22A)
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S135 The significance of pulmonary annulus size in the surgical management of
transposition of the great arteries with ventricular septal defect and
pulmonary stenosis
Chun Soo Park, MD, Dong-Man Seo, MD, PhD, Jeong-Jun Park, MD, PhD,
Young Hwue Kim, MD, PhD, and In-Sook Park, MD, Seoul, Republic of Korea
We assumed that in some of the patients who may be candidates for aortic translocation, an arterial
switch operation can be performed. An arterial switch operation was possible in 2 patients with
around 23 of the Z-score of the pulmonary annulus despite bicuspid pulmonary valve with
acceptable outcome.
139 Port-access minimally invasive surgery for atrial septal defects: A 10-year
single-center experience in 166 patients
Nicola Vistarini, MD, Marco Aiello, MD, Gabriella Mattiucci, MD, Alessia Alloni, MD,Barbara Cattadori, MD, Carmine Tinelli, MD, Carlo Pellegrini, MD,
Andrea Maria D’Armini, MD, and Mario Vigano`, MD, Pavia, Italy
We reviewed retrospectively our series of 166 patients operated for atrial septal defect with
a minimally invasive surgical approach. From our experience, the port-access surgery is a safe,
reproducible, and cosmetic operation, providing an excellent outcome and an effective correction,
and could be now considered the standard treatment option.Cardiothoracic
Transplantation (TX)146 Acute right ventricular failure after pediatric cardiac transplant: Predictors
and long-term outcome in current era of transplantation medicine
Aparna Hoskote, MD, MRCP, Catherine Carter, MSc, MPH, RN, Phillip Rees, MB, FRCP,
Martin Elliott, MD, FRCS, Michael Burch, MD, FRCP, FRCPCH, and
Katherine Brown, MPH, MRCP, London, United Kingdom
Early right ventricular failure (RVF) was identified in 33/129 (25%) pediatric heart transplant
recipients and was significantly linked to the primary diagnosis and pretransplant pulmonary
vascular resistance (PVR). Surprisingly, 23/117 (20%) with RVF had PVR within predefined
acceptable range. However, over time, only pretransplant elevated PVR independently predicted
mortality.
154 Implementation of a management guideline aimed at minimizing the severity
of primary graft dysfunction after lung transplant
Judy Currey, PhD, RN, David V. Pilcher, MD, Andrew Davies, MD, Carlos Scheinkestel, MD,
Mari Botti, PhD, RN, Michael Bailey, PhD, MSc, BSc, and Greg Snell, MD, Burwood and
Melbourne, Victoria, Australia
In a preinterventional and postinterventional study, implementation of an evidence-based algorithm
to manage hemodynamic and respiratory status after lung transplant was associated with reduced
severity of graft dysfunction within the first 72 hours. Postoperative care protocols may provide
a template for further studies of novel therapies for primary graft dysfunction.(continued on page 24A)
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Management (PM)24A The Journal of Thoracic an162 Magnesium supplementation during cardiopulmonary bypass to prevent
junctional ectopic tachycardia after pediatric cardiac surgery: A randomized
controlled study
Ana M. Manrique, MD, Margarita Arroyo, MD, Yan Lin, PhD, Samar R. El Khoudary, PhD, MPH,
Erin Colvin, RN, BSN, CCRN, Steven Lichtenstein, MD, Constantinos Chrysostomou, MD,
Richard Orr, MD, Edmund Jooste, MD, Peter Davis, MD, Peter Wearden, MD, PhD,
Victor Morell, MD, and Ricardo Munoz, MD, Pittsburgh, Pa
We conducted a randomized clinical trial in 99 children to analyze the role of supplementation with
magnesium sulfate during CPB in pediatric patents undergoing cardiac surgery. Magnesium
supplementation reduces the incidence of hypomagnesemia and JET at the CICU admission, and this
effect seems to be dose related.
170 Cardiopulmonary bypass flow rate: A risk factor for hyperlactatemia after
surgical repair of secundum atrial septal defect in children
Boban P. Abraham, MD, Parthak Prodhan, MBBS, Robert D. B. Jaquiss, MD, Adnan T. Bhutta, MD,
Jeffrey M. Gossett, MS, Michiaki Imamura, MD, PhD, Charles E. Johnson, RN, CCP,
Michael L. Schmitz, MD, William R. Morrow, MD, and Umesh Dyamenahalli, MD, Little Rock, Ark
Cardiopulmonary bypass flow rate less than 100 mL/min-1/kg-1 was associated with a 7.67-fold
increased risk of postoperative hyperlactatemia in children undergoing atrial septal defect repair.
174 Prevention of ischemia/reperfusion-induced pulmonary dysfunction after
cardiopulmonary bypass with terminal leukocyte-depleted lung reperfusion
Hiroshi Kagawa, MD, Kiyozo Morita, MD, Ryuichi Nagahori, MD, Gen Shinohara, MD,
Katsushi Kinouchi, MD, and Kazuhiro Hashimoto, MD, Tokyo, Japan
Ischemia/reperfusion-induced pulmonary dysfunction after cardiopulmonary bypass leads to high
morbidity and mortality. In neonatal piglets with 180 minutes of cardiopulmonary bypass, terminal
leukocyte-depleted lung reperfusion with hypoxemic blood had a protective effect against ischemia/
reperfusion-induced pulmonary dysfunction by reducing endothelial damage, cytokine release, and
leukocyte activation.Evolving Technology/
Basic Science (ET/BS)181 Effects of novel synthetic serine protease inhibitors on postoperative blood loss,
coagulation parameters, and vascular relaxation after cardiac surgery
Ga´bor Szabo´, MD, PhD, Ga´bor Veres, MD, Tama´s Radovits, MD, Humaira Haider, MD,
Nelli Krieger, MD, Susanne Ba¨hrle, MD, Christiane Miesel-Gro¨schel, MTA,
Silke Niklisch, MTA, Matthias Karck, MD, and Andreas van de Locht, PhD, Heidelberg, Germany,
Budapest, Hungary, and Leipzig, Germany
Effects of 2 novel synthetic small-molecule serine protease inhibitors on blood loss and coagulation
were examined in a canine model of cardiopulmonary bypass. CU-2010 and CU-2020 reduced blood
loss as much as aprotinin but with a more favorable anticoagulation. In addition, neither aprotinin nor
the novel inhibitors influenced vascular relaxation.
189 The role of mitochondrial DNA alterations in esophageal squamous cell
carcinomas
Chen-Sung Lin, MD, Shi-Chuan Chang, MD, PhD, Liang-Shun Wang, MD, Teh-Ying Chou, MD,
PhD, Wen-Hu Hsu, MD, Yu-Chung Wu, MD, and Yau-Huei Wei, PhD, Taipei, Taiwan
Mitochondrial DNA alterations were found to associate with the clinical features and prognosis of
ESCC. D310 variants alteration and copy number increase of mtDNA in tumor tissues suggest
a mechanism of mtDNA instability and clonal expansion in the carcinogenesis and progression of
ESCC from the viewpoint of mtDNA transmission.(continued on page 26A)
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S198 Transcatheter valve insertion in a model of enlarged right ventricular outflow
tracts
Adeline Basquin, MD, Emmanuelle Pineau, MD, Louise Galmiche, MD, Damien Bonnet, MD, PhD,
Daniel Sidi, MD, PhD, and Younes Boudjemline, MD, PhD, Paris, France
Transcatheter pulmonary valve insertion has recently emerged as an alternative to surgery but is
presently limited to the small number of patients who have RV-PA conduits. We report here the use of
an intravascular device in a model of animals with enlarged RVOTs and pulmonary valve
incompetence.
209 Impairment of human cell–based vasculogenesis in rats by
hypercholesterolemia-induced endothelial dysfunction and rescue with
L-arginine supplementation
Erik J. Suuronen, PhD, Samir Hazra, BSc, Pingchuan Zhang, MD, PhD, Renaud Vincent, PhD,
Premkumari Kumarathasan, PhD, Yan Zhang, MD, MSc, Joel Price, MD, Vincent Chan, MD,
Frank W. Sellke, MD, Thierry G. Mesana, MD, PhD, John P. Veinot, MD, and Marc Ruel, MD, MPH,
Ottawa, Ontario, Canada, and Boston, Mass
In this study, endothelial dysfunction inhibited in vivo vasculogenic cell therapy with healthy
functional human cells, suggesting a role for substrate modification to improve results.Brief Clinical Reports 217 Rapid progression of Barrett’s esophagus into adenocarcinoma in a combined
lung and kidney transplant recipient
Waleed Saleh, MD, Andre Duranceau, MD, Jocelyne Martin, MD, Nicolas Noiseux, MD,
Charles Poirier, MD, and Pasquale Ferraro, MD, Montreal, Quebec, Canada
218 Nonobstructive ectopic accessory mitral valve tissue in association with left
ventricular apical aneurysm
Lokeswara Rao Sajja, MS, MCh, MD, FACS, and
Gopichand Mannam, FRCS (Glasg), FRCS(Ed), FRCS (CT), Hyderabad, IndiaBrief Technique Reports 221 Hybrid occlusion of a paravalvular leak with an Amplatzer Septal Occluder
after mechanical aortic and mitral valve replacement
Nora Lang, MD, Rainer Kozlik-Feldmann, MD, Robert Dalla Pozza, MD, Martin Hinterseer, MD,
Ralf Sodian, MD, Jan Abicht, MD, Christian Kowalski, MD, Heinrich Netz, MD,
Bruno Reichart, MD, and Christoph Schmitz, MD, Munich, Germany
222 Complete lung parenchyma–sparing resection of the right main stem bronchus
and bronchus intermedius
Justin H. Booth, BS, Roosevelt Bryant III, MD, Ara Vaporciyan, MD, and David L. S. Morales, MD,
Houston, Tex
224 Use of unidirectional endobronchial valves for the treatment of giant
emphysematous bulla
Mario Santini, MD, Alfonso Fiorello, MD, Vincenzo Giuseppe Di Crescenzo, MD,
Giovanni Vicidomini, MD, PhD, Luigi Busiello, MD, and Paolo Laperuta, MD, Naples, Italy(continued on page 28A)
d Cardiovascular Surgery c January 2010
28A The Journal of Thoracic an
Table of Contents (continued)G
TS
A
CD
CH
D
TX
PM
ET/B
S226 Right ventricular outflow tract reconstruction using a valved femoral vein
homograft
Pranava Sinha, MD, Sachin Talwar, MCh, Achintya Moulick, MD, and Richard Jonas, MD,
Washington, DCBrief Research Reports 229 Radial artery versus saphenous vein graft patency: Meta-analysis of
randomized controlled trials
Umberto Benedetto, MD, Emiliano Angeloni, MD, Simone Refice, MD, and Riccardo Sinatra, MD,
Rome, Italy
231 Cost of thoracic endovascular aortic repair versus open repair and
implications for the US health care system
Karen L. Walker, BA, MHS, Paul Lipori, BA, MBA, W. Anthony Lee, MD, and
Thomas Mark Beaver, MD, Gainesville, FlaLetters to the Editor 233 Minimal extracorporeal circulation is a promising alternative for off-pump
revascularization in adults
Thomas Puehler, MD, Alois Philipp, ECCP, and Christof Schmid, MD, Regensburg, Germany
233 Reply to the Editor
Francesco Formica, MD, Italy
234 Lung ventilation/perfusion may reduce pulmonary injury during
cardiopulmonary bypass
Francisco Igor B. Macedo, MD, Enisa M. Carvalho, Edward Gologorsky, MD, and
Tomas A. Salerno, MD, Miami, Fla
236 Reply to the Editor
Hajime Imura, MD, Gianni D. Angelini, FRCS, Saadeh M. Suleiman, DSc, and
Raimondo Ascione, FRCS, Tokyo, Japan, and Bristol, United Kingdom
237 Pulmonary autograft for mitral valve replacement: Making a simple
procedure complex?
Khaled E. Al-Ebrahim, FRCSC, Jeddah, Saudi Arabia
237 Reply to the Editor
A. Sampath Kumar, MCh, New Delhi, India
238 Optimal surgical approach for repair of aortopulmonary window with aortic
origin of the right pulmonary artery
Tetsuya Kitagawa, MD, PhD, Takashi Kitaichi, MD, PhD, and Homare Yoshida, MD, PhD,
Tokushima, Japan(continued on page 30A)
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S238 Reply to the Editor
Masahiro Yoshida, MD, PhD, and Masahiro Yamaguchi, MD, PhD, Kobe and Akashi, Japan
239 Saphenous vein harvest with the Mayo extraluminal dissector: Is endothelial
function preserved?
Michael R. Dashwood, PhD, Stephen Fremes, MD, MSc, and Domingos S. R. Souza, MD, PhD,
London, United Kingdom, Toronto, Ontario, Canada, and O¨rebro, Sweden
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